Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (231-240 of 300) with videos related to

Pageof 30
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.
Acta Neuropathologica|March 9, 2017
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementiaJennifer S Yokoyama, Celeste M Karch, Chun C Fan, et al.
Cell|January 30, 2026
Molecular features of human pathological tau distinguish tauopathy-associated dementiasMukesh Kumar, Christoph N Schlaffner, Shaojun Tang, et al.
Nature|September 30, 2017
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathyYang Shi, Kaoru Yamada, Shane Antony Liddelow, et al.
Alzheimer Disease and Associated Disorders|September 13, 2019
Frequency of the TREM2 R47H Variant in Various Neurodegenerative DisordersAriane H Ayer, Kevin Wojta, Eliana Marisa Ramos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2024
Better cardiovascular health is associated with slowed clinical progression in autosomal dominant frontotemporal lobar degeneration variant carriersAnna M VandeBunte, Hyunwoo Lee, Emily W Paolillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Brain : a Journal of Neurology|March 29, 2022
Proposed research criteria for prodromal behavioural variant frontotemporal dementiaMegan S Barker, Reena T Gottesman, Masood Manoochehri, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Pageof 30

Showing results (231-240 of 300) with videos related to

Sort By:
Pageof 30
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.
Acta Neuropathologica|March 9, 2017
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementiaJennifer S Yokoyama, Celeste M Karch, Chun C Fan, et al.
Cell|January 30, 2026
Molecular features of human pathological tau distinguish tauopathy-associated dementiasMukesh Kumar, Christoph N Schlaffner, Shaojun Tang, et al.
Nature|September 30, 2017
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathyYang Shi, Kaoru Yamada, Shane Antony Liddelow, et al.
Alzheimer Disease and Associated Disorders|September 13, 2019
Frequency of the TREM2 R47H Variant in Various Neurodegenerative DisordersAriane H Ayer, Kevin Wojta, Eliana Marisa Ramos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2024
Better cardiovascular health is associated with slowed clinical progression in autosomal dominant frontotemporal lobar degeneration variant carriersAnna M VandeBunte, Hyunwoo Lee, Emily W Paolillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Brain : a Journal of Neurology|March 29, 2022
Proposed research criteria for prodromal behavioural variant frontotemporal dementiaMegan S Barker, Reena T Gottesman, Masood Manoochehri, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Pageof 30